The Venture Codex Logo

The Venture Codex

Overview

Investment firm targeting early-stage life sciences companies in cancer.

Founded

2018

Deals · 12mo

2

Stage focus

Series A
Series B
Series C

Geographic focus

United States

Sector focus

—

Investment portfolio

10rounds
NAMEDATESIZE
Allotera Therapeutics
Jul 2026Participated
$35 MSeries C
AI Proteins
Nov 2025Participated
$42 MSeries A
Predicta Biosciences
Oct 2025Participated
$23 MSeries A
Geneoscopy
Jan 2025Participated
$105 MSeries C
AI Proteins
Nov 2022Led
$18 MSeed
NextRNA Therapeutics
Mar 2022Led
$56 MSeries A
Geneoscopy
Nov 2021Led
$105 MSeries B
Mana Therapeutics
Jan 2021Led
$35 MSeries A
C4 Therapeutics
Jun 2020Participated
$170 MSeries B
Geneoscopy
Oct 2019Participated
$7 MSeries A
Allotera Therapeutics
Jul 2026Participated
$35 MSeries C
AI Proteins
Nov 2025Participated
$42 MSeries A
Predicta Biosciences
Oct 2025Participated
$23 MSeries A
Geneoscopy
Jan 2025Participated
$105 MSeries C
AI Proteins
Nov 2022Led
$18 MSeed
NextRNA Therapeutics
Mar 2022Led
$56 MSeries A
Geneoscopy
Nov 2021Led
$105 MSeries B
Mana Therapeutics
Jan 2021Led
$35 MSeries A
C4 Therapeutics
Jun 2020Participated
$170 MSeries B
Geneoscopy
Oct 2019Participated
$7 MSeries A
10
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Lightchain Capital: 10 funding rounds are recorded in the selected participation categories.All available history.
Lightchain Capital: 10 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series A23
Series B11
Series C+02

Monthly Deal Activity

Lightchain Capital: 10 deals are recorded across 85 months.All available history.
Lightchain Capital: 10 deals are recorded across 85 months. All available history
MonthDeals
Oct '191
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '201
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '211
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '251
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '261
Aug '260
Sep '260
Oct '260

Sector Breakdown

Lightchain Capital: Health & Life Sciences is the largest displayed sector by deal count (10 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Lightchain Capital: Health & Life Sciences is the largest displayed sector by deal count (10 deals). All available history
SectorDeals
Health & Life Sciences10
AI & Machine Learning2

Deal Size Distribution

Lightchain Capital: 10 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Lightchain Capital: 10 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M2
$25M-$50M3
$50M-$100M1
$100M-$250M3
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Lightchain Capital: United States has the largest recorded deal count among the displayed regions (10 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Lightchain Capital: United States has the largest recorded deal count among the displayed regions (10 deals). All available history
RegionDeals
United States10
Lightchain Capital: 20 co-investors are shown, with Cobro Ventures sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Lightchain Capital: Led accounts for 40% and participating for 60% of round participation.All available history.
Lightchain Capital: Led accounts for 40% and participating for 60% of round participation. All available history
CategoryDeals (count)Share (%)
Led440%
Participating660%
Lightchain Capital: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Lightchain Capital: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led4100%

Team

No team members found for this fund.